These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16159063)

  • 21. [Cerebral secondary prevention--clopidogrel alone or in combination with ASS].
    Nitschmann S; Hartung HP; Siebler M
    Internist (Berl); 2005 Nov; 46(11):1278-82. PubMed ID: 16211404
    [No Abstract]   [Full Text] [Related]  

  • 22. Rationale and design of a randomized, double-blind trial comparing the effects of a 3-month clopidogrel-aspirin regimen versus aspirin alone for the treatment of high-risk patients with acute nondisabling cerebrovascular event.
    Wang Y; Johnston SC;
    Am Heart J; 2010 Sep; 160(3):380-386.e1. PubMed ID: 20826243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MATCH results: implications for the internist.
    Lutsep HL
    Am J Med; 2006 Jun; 119(6):526.e1-7. PubMed ID: 16750967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiplatelet agents and randomized trials.
    Diener HC
    Rev Neurol Dis; 2007; 4(4):177-83. PubMed ID: 18195669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in usage of alternative antiplatelet therapy after stroke and transient ischemic attack.
    Hills NK; Johnston SC
    Stroke; 2008 Apr; 39(4):1228-32. PubMed ID: 18323509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adding aspirin to clopidogrel after TIA and ischemic stroke: benefits do not match risks.
    Hankey GJ; Eikelboom JW
    Neurology; 2005 Apr; 64(7):1117-21. PubMed ID: 15824331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial.
    Markus HS; Droste DW; Kaps M; Larrue V; Lees KR; Siebler M; Ringelstein EB
    Circulation; 2005 May; 111(17):2233-40. PubMed ID: 15851601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stroke prevention. MATCHing therapy to the patient with TIA.
    Weir NU; Demchuk AM; Buchan AM; Hill MD
    Postgrad Med; 2005 Jan; 117(1):26-30. PubMed ID: 15672888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual antiplatelet therapy with clopidogrel and aspirin for secondary stroke prevention.
    Wang Y; Chen W; Wang Y
    Curr Cardiol Rep; 2015 Oct; 17(10):89. PubMed ID: 26294261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.
    Fox KA; Mehta SR; Peters R; Zhao F; Lakkis N; Gersh BJ; Yusuf S;
    Circulation; 2004 Sep; 110(10):1202-8. PubMed ID: 15313956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual antiplatelet drug resistance in patients with acute coronary syndrome.
    Guha S; Sardar P; Guha P; Roy S; Mookerjee S; Chakrabarti P; Deb PK; Chaudhuri U; Deb S; Karmakar R; Dasgupta AK; Lahiri P
    Indian Heart J; 2009; 61(1):68-73. PubMed ID: 19729693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiplatelet agents for stroke prevention following transient ischemic attack.
    Weinberger J
    South Med J; 2008 Jan; 101(1):70-8. PubMed ID: 18176296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Switching from aspirin to clopidogrel in patients with aspirin resistance after an ischemic stroke. Is it a good solution?
    Castilla-Guerra L; Fernandez-Moreno Mdel C; Navas-Alcantara MS; Jimenez-Gonzalo F
    Eur J Intern Med; 2014 Mar; 25(3):e40-1. PubMed ID: 24484620
    [No Abstract]   [Full Text] [Related]  

  • 34. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
    Biller J
    J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of aspirin in MATCH.
    Bath P
    Lancet; 2004 Nov 6-12; 364(9446):1662; author reply 1662-3. PubMed ID: 15530618
    [No Abstract]   [Full Text] [Related]  

  • 36. Extended use of clopidogrel and aspirin after ischemic stroke.
    Davis K; Dietrich E
    Am J Health Syst Pharm; 2016 May; 73(10):611-2. PubMed ID: 27147209
    [No Abstract]   [Full Text] [Related]  

  • 37. Clopidogrel in addition to aspirin reduces one-year major adverse cardiac and cerebrovascular events in unselected patients with non-ST segment elevation myocardial infarction.
    Zeymer U; Gitt AK; Zahn R; Jünger C; Bauer T; Köth O; Heer T; Wienbergen H; Gottwik M; Senges J
    Acute Card Care; 2008; 10(1):43-8. PubMed ID: 17924233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
    Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lessons from MATCH for future randomised trials in secondary prevention of stroke.
    Rothwell PM
    Lancet; 2004 Jul 24-30; 364(9431):305-7. PubMed ID: 15276368
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of clopidogrel plus ASA vs. ASA early after TIA and ischaemic stroke: a substudy of the CHARISMA trial.
    Hankey GJ; Johnston SC; Easton JD; Hacke W; Mas JL; Brennan D; Mak KH; Bhatt DL; Fox KA; Topol EJ;
    Int J Stroke; 2011 Feb; 6(1):3-9. PubMed ID: 21205234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.